The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
MED3000 For Women #3
In RNS Number 3928V dated 5 th April 2023 James Barder confirms that following the approval for
Eroxon Stimgel by the FDA in the US, the next priority would be another addition to the Eroxon®
pipeline; so the next version of Eroxon will carry the Eroxon trademark. Futura Medical subsequently
entered into a marketing agreement with Halion for Eroxon Stimgel in the US but made no mention of
the marketing rights for the second addition to the Eroxon pipeline. Since this second version of
MED3000/Eroxon carries the Eroxon trademark, it must have formed part of the agreement for the
Eroxon stimgel marketing rights in the US. This is necessarily the case because Halion would not have
agreed to promote the Eroxon trademark in the US whilst allowing Futura to retain the marketing rights
for a MED3000 product bearing the Eroxon trademark. So there must be a forward agreement in place
between Futura and Halion which does not involve any consideration at this stage; this agreement will
stipulate an agreed consideration, milestone payments and royalty payments after the second version of
MED3000 is approved by the FDA.
As you begin to understand the potential magnitude of MED3000/Eroxon as it applies to women’s
sexual health needs, you will realise that this new version of MED3000/Eroxon, which has only been
described in rather vague terms by Futura at this stage, will have affected the usual expected power
dynamics between little Futura versus “the giant” in their negotiations.
Clearly moving
Reviews having no effect on online sales boots as Eroxon still matching Cialis OTC sales every few minutes etc ahead of viagra sildefanel ( maybe they would be higher )
Let see what September update brings … repeat and
An Instore that’s the key
Thanks for that bucolic.i actually burst out laughing when i read that.it's a shame that the ratings are being held down by obviously spurious re views,as whilst one would expect and accept some degree of negative reviews,there is clearly a significant element motivated by ill will towards the product/company.im back in by the way,as expecting a good response to results.only my opinion of course.
if you thought liarbooth's dirty fingerprints were all over that review, t.i., check this one from amazon: 'this product did not work for me. i followed the instructions precisely. i would question how it could work. as i understand it, the mode of action is supposed to be that the application of the cream to the head of the ***** causes a cooling effect as the cream (whose main ingredient is ethanol, i.e. alcohol) evaporates. as the ***** then warms up again, this supposedly triggers the generation of nitric oxide, which should cause the corpora cavernosa to engorge. well, the head of my ***** did not cool, and therefore did not warm up again. it seems that no nitric oxide was generated and therefore no engorgement of the corpora cavernosa occurred. many antiseptic hand gels contain alcohol, so by the same logic, putting any alcohol gel on the head of the ***** should work? i don't think so.'
almost word for word from his bitter posts on here and advfn, especially the hand gel comparison. it gives the little stock basher something to do now that he's been banned from advfn as well as here!
Interesting to note the reference to 'no active ingredient"personally i doubt that this is a phrase that would readily spring to the mind of the average disappointed punter. it is of course a key phrase in the well known derampers lexicon! lol
Look at this clown lol on boots site … selling trending every minute ( lol he will never shop at boots again… desperate
Absolute rubbish
Leeps 12
4 hours ago
This is a rubbish product, boots should be disgusted. Read the clinic review, there is no active ingredient. It's a poor form of ky gelly. Boots I will never shop with you again, disgusted
Did you receive a free sample of this product?No
One of the problems of living in a capitalist system ! There have been complaints about EROXON being TOO EXPENSIVE and yet clearly someone considers the product is SO GOOD that there is money to be made by making a turn by doubling the price !
Not terribly good for BOOTS, AMAZON or even FUTURA but blows the gaff on so many of those critical comments which are clearly fallacious and a deliberate attempt at bad mouthing what is clearly a highly successful product in many people’s estimation .
GLA long term FUMSTERS.
Not odd to say as that's what it says. Blocked due to our filtering policy and requesting my name and email to allow through which clearly not going to complete. May be Google but no big issue
Odd to say www.eroxongel.com website is "blocked" when clearly it isn't. I'm not too sure if this fake website is a good or bad thing... probably not great for our company and needs taking down.
Site doesn't seem to be blocked, just accessed it. Sells Eroxon almost triple price, obviously anywhere in the world. Maybe a good omen that scammers get interested, but Futura should hurry up to get the gel to the market in rest of Europe and world.
Seems to be blocked now probably by futura
Chancers looking to buy and sell for a quick profit no doubt. Think it is or was happening on Amazon as well.
Seems to be blocked now probably by futura
Chancers looking to buy and sell for a quick profit no doubt. Think it is or was happening on Amazon as well.
Good Morning all , everyone enjoying the summer holidays ?
Came across this article this morning, thought I share here :
https://finance.yahoo.com/news/58-institutional-ownership-futura-medical-054527488.html
Www.eroxongel.com
Looks like Eroxon but more than twice the price, is it a scam? Certainly doesn’t help the brand reputation.
Am appy to see this wel loff the 46p as was predited
Which it is …. Been trending on boots for last 2 weeks leaving viagra and others in the dust and matching Cialis together in online sales …..this after Eli Lilly has given CT a huge marketing advertising campaign ( see ads they everywhere even the pharmacies in Anglesey where I was recently) ……and CT price has been discounted by boots (30% cheaper )
Amazon sales 4k per month
So yes build a brand and eventually the SP will follow
My 'LTHs long face' is a little less long today, after a rather turbulent week! In fact, a quick look at my portfolio daily progress shows FUM as the one one in blue today! That's about the first time that's happened!
Yes its obvious.
Next push will reach 75p -80p
Excuse me for my English I am from a different country then the UK*
In my opinion. Futura will get on bigger funds to take out the small day traders. This is the only way they can make big steps in terms of growth(share price). The board also knows about these smaller investors trading. The share price is actually 1-2 pounds 100%. They are selling good and made a big deal with the biggest consumer-health seller in the world Haleon. Wich might actually end up buying Futura if the sales are good!
Patience is know key for all the serious and big investors. I think the company will sell between 2-5 pound in 2-3 years…
Toli
13th Aug £34k in 3 large tranches
14th Aug - £62k In 3 tranches
15th Aug - a whopping £135,000 in about 5 tranches
16th Aug £42k in 3 tranches.
17th Aug £126,000
I may be looking at this too simply but if the above sales, (Around £420,000 worth) were enough to drop the SP to recent levels then when the buyers truely rush in I am quite excited about the effect on the SP. Would love to see it over react upwards.
"..now we need to know how and when it is going to be delivered to benefit us".
Typically, there are two types of investors invested in this company. The large heavy weights, who are in for the future success and decent long term returns in dividends. The other, speculative PIs who are awaiting a sharp rise in the SP so they can cash in. One has to ask the question, who are the company's main priority. The signs are that this is going to be big in the long term, when there is worldwide availability of the product. The company has a road map they are following and are not likely to deviate in favour of short-term SP spikes.
My view is that the company is not overly joyed by the languishing SP, however it is possibly not their main focus ATM. The company needs friends in the city and a broker with connections for the SP to reflect the true de-risked value.
The SP was moving between 53p - 58 for weeks on end.
A sale for £156,00o of shares went through about ten days ago which is massive for this share and since then the SP has inched down and the selling of large holdings £10 plus was persistent.
13th Aug £34k in 3 large tranches
14th Aug - £62k In 3 tranches
15th Aug - a whopping £135,000 in about 5 tranches
16th Aug £42k in 3 tranches.
17th Aug £126,000
Today the picture is different there are no large sells and the delayed one of £36k is made to look like a sell but has to be a buy so I believe the large seller has left and the support is around £46p which incredibly is only 4p off the pre serious news which was 42p.I believe it shall now move upwards and onwards and fly when the results come out.Every one is entitled to my opinion
Hi Jet7, my 'friends (the nutters)' have all gone to sleep at the moment since the demise of LiarBOoth. As ADVFN is a den of stock bashing iniquity, I'll let sleeping dogs lie for the moment - and take a little break! Meantime, I'm...back in the room! My buy order at 50p was filled on Monday, so now I can be just as long faced as the regular LTHs! Oh well! But I'm still quids in for selling at 60p a couple of weeks ago, so fingers crossed! GLA (except that other nutter, Toli)!